Detailed Notes on Suvorexant
glycerol phenylbutyrate will reduce the extent or impact of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Glycerol phenylbutyrate can be a weak inducer of CYP3A4. Monitor for reduced efficacy of CYP3A4 substrates that have a narrow therapeutic index.
Sti